Johnson Johnson to Expand Partnership with U.S. Department of Health Human Services to Accelerate the Discovery of Potential COVID-19 Treatments: Janssen strengthens collaboration with Biomedical Advanced Research and Development Authority (BARDA) in an effort to stem the threat of the global COVID-19 outbreak
Published in PR Newswire
(18.02.2020)
Get full text
Newsletter
GlaxoSmithKline collaborates with Biomedical Advanced Research and Development Authority
Published in M2 Pharma
(24.05.2013)
Get full text
Newsletter
Johnson Johnson Announces Collaboration with U.S. Department of Health Human Services to Accelerate Development of a Potential Novel Coronavirus Vaccine: Janssen joins forces with Biomedical Advanced Research and Development Authority (BARDA) to protect communities against threat of a global COVID-19 pandemic
Published in PR Newswire
(11.02.2020)
Get full text
Newsletter
Opiant Pharmaceuticals Announces Contract with Biomedical Advanced Research and Development Authority for Up to $4.6 Million to Accelerate Development of OPNT003, Nasal Nalmefene, for Treatment of Opioid Overdose
Published in NASDAQ OMX's News Release Distribution Channel
(20.09.2018)
Get full text
Newsletter
Press Release: Opiant Pharmaceuticals Announces Contract with Biomedical Advanced Research and Development Authority for Up to $4.6 Million to Accelerate Development of OPNT003, Nasal Nalmefene, for Treatment of Opioid Overdose
Published in Dow Jones Institutional News
(20.09.2018)
Get full text
Newsletter
Terumo BCT Announces a $17.4 Million Funding Contract from the Biomedical Advanced Research and Development Authority (BARDA)
Published in PR Newswire
(21.06.2016)
Get full text
Newsletter
Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract and Increase Funding for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine: Funding will be provided by the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services
Published in PR Newswire
(01.10.2013)
Get full text
Newsletter
Johnson Johnson Innovation and Children's National Health System to Launch JLABS @ Washington, DC at the new Children's National Research and Innovation Campus in 2020: The Biomedical Advanced Research and Development Authority (BARDA) collaborates with JLABS to stimulate innovation and incubation of technologies that improve health security and response through companies focused on public health threats and emerging infectious diseases with residency at JLABS @ Washington, DC
Published in PR Newswire
(09.04.2019)
Get full text
Newsletter
U.S. Biomedical Advanced Research and Development Authority (BARDA) Extends Contract with Protein Sciences Corporation
Published in PR Newswire
(17.06.2014)
Get full text
Newsletter
Johnson Johnson Innovation Launches Reimagining Respiratory Protection QuickFire Challenge in Collaboration with the U.S. Department of Health and Human Services: Johnson & Johnson Innovation, JLABS teams with the Biomedical Advanced Research and Development Authority (BARDA) to advance new technologies to improve global pandemic preparedness against respiratory infection outbreaks
Published in PR Newswire
(30.10.2018)
Get full text
Newsletter
NewLink Genetics and Merck receive Ebola vaccine contract from US Biomedical Advanced Research and Development Authority
Published in M2 Pharma
(23.12.2014)
Get full text
Newsletter
The Biomedical Advanced Research and Development Authority extends collaboration with Pfenex
Published in M2 Pharma
(03.10.2013)
Get full text
Newsletter
The Biomedical Advanced Research and Development Authority
Published in Federal register
(14.08.2018)
Get full text
Newspaper Article